Fox Health

COVID-19 patient can only smell foul odors.

Temporary loss of smell, or anosmia, is a common symptom of COVID-19, and one study recently determined the cell types in the upper nasal cavity most vulnerable to SARS-CoV-2 infection.

Get the latest news on COVID-19 here.

Amid the ongoing coronavirus pandemic, which is better, a face mask or face shield? 

A World Health Organization (WHO) spokesperson recently described the coronavirus pandemic as “one big wave” and cautioned against complacency in the northern hemisphere summer. 

The novel coronavirus has infected a pet cat in England, officials in the country said this week. 

With a number of states requiring face masks in public, some may be wondering: is it safe to wear a mask while working out? 

A small BBQ in Texas turned deadly after 14 members of one family test positive for the novel coronavirus.

A coronavirus outbreak cropped up at a Massachusetts hospital after an employee traveled to a virus hot spot, officials said.

A California study finds those with keen sense of smell have less risk of dementia.

German study found detection dogs could determine COVID-19 in saliva with 94 percent accuracy

One California man will undergo reconstructive surgery after most of his fingers were amputated during a two-month hospital stay for coronavirus. 

Ger the latest news on COVID-19 here.

Dr. Scott Gottlieb, former FDA commissioner, and Health and Human Services Secretary Alex Azar advocated for school reopenings contingent on local virus conditions with CBS’s “Face the Nation.”

The novel coronavirus has claimed the life of its youngest victim in Florida, a 9-year-old Putnam County girl identified as Kimora "Kimmie" Lynum. 

A Florida man who is deaf created specialized face masks for those who rely on lip-reading to communicate.

Study finds cinnamon supplement may help control blood sugar levels in people with prediabetes.

Salmonella outbreak is rapidly growing, according to the CDC, and no source of the infection has been identified.

Biotech company Moderna said on Monday that it has started dosing participants in the Phase III clinical trial for its coronavirus vaccine candidate.

The next few months will be crucial because the U.S. has "really incredible shots at therapeutics," Secretary Azar said.